Chr. Hansen has announced the appointment of Glenda Leong to the post of APAC Sales Director for Animal Health. Based in Singapore, Leong has more than 10 years of experience in building, growing and driving animal health businesses across the Asia-Pacific region.
The focus on curbing antibiotics usage is the main growth driver in APAC, and Chr. Hansen has a long-standing presence in key Asian probiotic markets where legislation and/or consumer preferences favor the use of probiotics in animal health.
The presence or risk of developing antibiotic resistance has led governments across Asia to increase the speed of reducing usage of antibiotics growth promoters (AGPs) while consumer demands from export and domestic markets are putting more focus on premium protein products.
“We are aiming for business growth in countries like China and Vietnam where we witness an increasing interest for science based probiotics. Glenda will play a key role for Chr. Hansen in meeting these ambitions in the APAC region,” says Vilson Simon, SVP of Animal Health.
“Having been in the animal nutrition industry for over 10 years, I am passionate about providing the best solutions for the industry to help them meet the regulatory requirements in safety and efficacy while optimizing their output,” says Leong. “I am excited to join Chr. Hansen, a leader in natural solutions for food, health and agriculture. I look forward to working with the Chr. Hansen team in APAC to drive the growth of probiotics and silage inoculants that will help the industry be more productive and sustainable.”
Prior to joining Chr. Hansen, Leong held leadership positions in AB Vista Singapore and Provimi Singapore.
